Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

836 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients.
Castro P, Plana M, González R, López A, Vilella A, Nicolas JM, Gallart T, Pumarola T, Bayas JM, Gatell JM, García F. Castro P, et al. Among authors: gatell jm. AIDS Res Hum Retroviruses. 2013 Jan;29(1):68-76. doi: 10.1089/AID.2012.0145. Epub 2012 Dec 16. AIDS Res Hum Retroviruses. 2013. PMID: 23121249 Free PMC article. Clinical Trial.
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
García F, Plana M, Arnedo M, Brunet M, Castro P, Gil C, Vidal E, Millán O, López A, Martorell J, Fumero E, Miró JM, Alcamí J, Pumarola T, Gallart T, Gatell JM. García F, et al. Among authors: gatell jm. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):823-30. doi: 10.1097/00126334-200407010-00009. J Acquir Immune Defic Syndr. 2004. PMID: 15213566 Clinical Trial.
Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.
Libois A, López A, Garcia F, Castro P, Maleno MJ, García A, Climent N, Arnedo M, Gallart T, Gatell JM, Plana M. Libois A, et al. Among authors: gatell jm. AIDS Res Hum Retroviruses. 2006 Jul;22(7):657-66. doi: 10.1089/aid.2006.22.657. AIDS Res Hum Retroviruses. 2006. PMID: 16831090
Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption.
Mestre G, Garcia F, Martinez E, Milinkovic A, Lopez A, León A, Mora B, Argelich R, Lozano JM, Peña J, Gatell JM, Plana M. Mestre G, et al. Among authors: gatell jm. AIDS Res Hum Retroviruses. 2008 Dec;24(12):1485-95. doi: 10.1089/aid.2008.0135. AIDS Res Hum Retroviruses. 2008. PMID: 19025397 Clinical Trial.
Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.
Miró JM, Manzardo C, Pich J, Domingo P, Ferrer E, Arribas JR, Ribera E, Arrizabalaga J, Loncá M, Cruceta A, de Lazzari E, Fuster M, Podzamczer D, Plana M, Gatell JM; Advanz Study Group. Miró JM, et al. Among authors: gatell jm. AIDS Res Hum Retroviruses. 2010 Jul;26(7):747-57. doi: 10.1089/aid.2009.0105. AIDS Res Hum Retroviruses. 2010. PMID: 20624069 Clinical Trial.
Effects of different antigenic stimuli on thymic function and interleukin-7/CD127 system in patients with chronic HIV infection.
Castro P, Torres B, López A, González R, Vilella A, Nicolas JM, Gallart T, Pumarola T, Sánchez M, Leal M, Vallejo A, Bayas JM, Gatell JM, Plana M, García F. Castro P, et al. Among authors: gatell jm. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):466-72. doi: 10.1097/QAI.0000000000000207. J Acquir Immune Defic Syndr. 2014. PMID: 24820104 Clinical Trial.
836 results